Deb Kientop

Deb Kientop, MBA brings over 25 years of experience in oncology drug development, starting in the cancer research labs at the University of Wisconsin, and moving into business development, medical affairs and clinical development roles within pharma and CRO. Her career has included thought leader engagement, product lifecycle planning, strategy development and execution for proposals and bid defenses, and corporate strategy and alliance management. Through her work with oncology investigators and patient advocacy organizations, she has been able to incorporate insights into patient-centric development strategies. Deb is also a published author and cancer patient advocate.

Prior to joining Synteract, Deb was the Vice President of Life Sciences at Inteliquet, a healthcare technology company. Previously, she held senior director strategy positions at two large CROs, as well as numerous biopharmaceutical organizations including MedImmune, MGI Pharma, and Eisai.

Deb holds a Bachelor of Science in Pharmacology and Toxicology, and a Master of Business Administration from the University of Wisconsin.

Anders Andrén

10 years’ experience within Strategic marketing/Product management for Plant Integration/Digitalisation

10 years’ experience as Product manager for Service portfolio within Lean manufacturing/expert services

Total experience of 30 years in the Food and Beverage industry

Bruce Linton

Bruce has a passion for entrepreneurship and making a positive difference in the world. He brings a wealth of experience in building strong technology driven companies, developing world-class teams, and positioning his companies in sectors driven by waves of public policy change. Bruce currently holds the positions of Founder and Chairman and CEO of Collective Growth Corporation; a special acquisition purpose company which went public on the NASDAQ exchange on May 1 2020. Bruce is a member of the Board of Directors and Chair of the Compensation Committee for Mind Medicine Inc., Executive Chairman for Gage Cannabis Co., Chairman of the Advisory Board for Red Light Holland Corp., is co-founder and Non-Executive Chairman of Óskare Capital, on the Board of the Canadian Olympic Foundation, Co-Chairman and past CEO of Martello Technologies and is Co-founder and Chairman of Ruckify. Is an active investor with Slang Worldwide Inc and with OG DNA Genetics Inc. He is the Founder and Former Chairman and CEO of Canopy Growth Corporation (CGC/WEED).

Nathan Mison

Nathan Mison is the Vice President of Government and Stakeholder Relations at Fire & Flower. Prior to joining Fire & Flower, Mr. Mison was the Principal of Mison & Associates, a national consulting firm that focuses on government relations, stakeholder consultation and executive counsel. Nathan is the co-chair of the National Cannabis Working Group for the Canadian Chamber of Commerce, the Chair of the Alberta Cannabis Council. founding member of NorthCanvas, an ancillary cannabis incubator, a member of the Alberta Cannabis Stakeholder Group and a founding member of the Alberta Cannabis Retailers Association. Nathan volunteers his time as the President of the Valley Zoo Development Society and is the co-founder of Politics on Tap. He has been married to Stacey for 16 years and has 3 incredible children.